drugset / Trial / NCT06020235

Nu-3 Gel for Infected Diabetic Foot Ulcers

NCT06020235 ↗

Phase 2 Not yet recruiting 60 enrolled Lakewood-Amedex Inc
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this clinical trial is to test a topical drug in patients with mild infections of their diabetic foot ulcer. The main questions it aims to answer are: What strength does the drug need to be in order to make the infection better? How frequently does the drug need to be applied in order to make the infection better? Participants will be asked to apply the medicine on their foot ulcer twice a day for 2 weeks and remain off of that foot during that time. Participants will receive the medication either once a day or twice a day, in either a 5% or 10% gel, or placebo. Researchers will compare the 5% and 10% gels to placebo to see if the infection improves.

Timeline

Start
2025-12
Primary completion
2026-06
Completion
2026-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Nu-3 Unknown 5 % Topical
Subject Nu-3 Unknown 10 % Topical

Indications

No indication recorded.